1. Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials. Issue 2 (December 2015) Authors: de Gruijl, Tanja; Koster, Bas; van den Hout, Mari; Sluijter, Berbel; Molenkamp, Barbara; Vuylsteke, Ronald; van Leeuwen, Paul; Scheper, Rik; van den Tol, Petrousjka; van den Eertwegh, Alfons Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗